Fig. 2From: A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbancesPercent of eyes with improvement in contrast sensitivity with glare of two or more patches (≥0.3 log units) by treatment groupBack to article page